Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
Aspire Biopharma (NASDAQ:ASBP) has successfully launched its innovative pre-workout supplement BUZZ BOMBā� at FitCon and FitExpo, distributing over 30,000 sample packs to attendees. The product features a unique sublingual delivery technology with 50mg of caffeine in four flavors: Tropical Fruit, Mixed Berry, Peach Mango, and Coffee Mocha.
The product differentiates itself through rapid absorption (under 2 minutes vs. traditional 20-30 minutes), convenient single-use packets, and precise energy management. Notable fitness figures including UFC fighter Bobby Maximus and MMA champion Brandon Copeland have provided positive testimonials. The product is now available for purchase through the company's e-commerce website buzzbomb.buzz.
Aspire Biopharma (NASDAQ:ASBP) ha lanciato con successo il suo innovativo integratore pre-allenamento BUZZ BOMBā� a FitCon e FitExpo, distribuendo oltre 30.000 confezioni di prova ai partecipanti. Il prodotto sfrutta una tecnologia di somministrazione sublinguale unica con 50 mg di caffeina ed ĆØ disponibile in quattro gusti: Frutta Tropicale, Mista di Frutti di Bosco, Pesca e Mango, e CaffĆØ Moka.
Si distingue per l'assorbimento rapido (meno di 2 minuti rispetto ai tradizionali 20-30 minuti), le pratiche bustine monouso e la gestione precisa dell'energia. Figure note del mondo fitness, tra cui il lottatore UFC Bobby Maximus e il campione MMA Brandon Copeland, hanno rilasciato testimonianze positive. Il prodotto ĆØ ora acquistabile sul sito e-commerce buzzbomb.buzz.
Aspire Biopharma (NASDAQ:ASBP) lanzó con Ć©xito su innovador suplemento pre-entrenamiento BUZZ BOMBā� en FitCon y FitExpo, repartiendo mĆ”s de 30.000 paquetes de muestra entre los asistentes. El producto emplea una tecnologĆa de administración sublingual Ćŗnica con 50 mg de cafeĆna y estĆ” disponible en cuatro sabores: Fruta Tropical, Mezcla de Bayas, Melocotón-Mango y CafĆ© Moka.
Se diferencia por su absorción rĆ”pida (menos de 2 minutos frente a los habituales 20-30 minutos), sus prĆ”cticos sobres de un solo uso y su gestión precisa de la energĆa. Figuras destacadas del fitness, incluido el luchador de la UFC Bobby Maximus y el campeón de MMA Brandon Copeland, han dado testimonios positivos. El producto ya estĆ” a la venta en la tienda online buzzbomb.buzz.
Aspire Biopharma (NASDAQ:ASBP)ź° FitConź³� FitExpoģģ ķģ ģ ģø ķ리ģķ¬ģģ 볓충ģ � BUZZ BOMBā�ģ� ģ±ź³µģ ģ¼ė”� ģ¶ģķģ¬ ģ°øź°ģė¤ģź² 30,000ź°� ģ“ģģ� ģķ ķ�ģ� ė°°ķ¬ķģµėė¤. ģ� ģ ķģ ģ¤ķ(ķ ė°�) ķ¬ģ¬ źø°ģ ģ� ģ ģ©ķ� 50 mgģ� 칓ķģ�ģ� ķØģ ķė©°, ģ“ė ź³¼ģ¼, ķ¼ķ© ė² ė¦¬, ķ¼ģ¹ ė§ź³ , ģ»¤ķ¼ ėŖØģ¹“ģ� ė� ź°ģ§ ė§ģ¼ė”� ģ ź³µė©ėė�.
ģ ķµģ ģø ģ ķģ� 20~30ė¶ź³¼ ė¬ė¦¬ 2ė¶� ģ“ė“ģ� ė¹ ė„ø ķ”ģ, ķ“ėź° ź°ķøķ� ģ¼ķģ� ķģ°ģ¹�, ģėģ§ ģ”°ģ ģ� ģ ė°ģ±ģ“ ķ¹ģ§ģ ėė�. UFC ķģ“ķ� ė°ė¹ ė§„ģ묓ģ¤ģ MMA ģ±ķ¼ģ� ėøėė� ģ½ķėė ė� ģ ėŖ ķ¼ķøėģ¤ ģøģ¬ė¤ģ“ ķøķģ� ģ ķģµėė�. ģ ķģ ķģ¬ ģ ģģź±°ė� ģ¬ģ“ķ� buzzbomb.buzzģģ źµ¬ė§¤ķ� ģ� ģģµėė¤.
Aspire Biopharma (NASDAQ:ASBP) a lancĆ© avec succĆØs son supplĆ©ment prĆ©-entraĆ®nement innovant BUZZ BOMBā� lors de FitCon et FitExpo, distribuant plus de 30 000 Ć©chantillons aux participants. Le produit utilise une technologie d'administration sublinguale unique avec 50 mg de cafĆ©ine et se dĆ©cline en quatre saveurs : Fruits tropicaux, MĆ©lange de baies, PĆŖche-Mangue et CafĆ© Moka.
Il se distingue par une absorption rapide (moins de 2 minutes contre 20-30 minutes habituellement), des sachets à usage unique pratiques et une gestion précise de l'énergie. Des figures reconnues du fitness, dont le combattant UFC Bobby Maximus et le champion MMA Brandon Copeland, ont donné des témoignages positifs. Le produit est désormais disponible à l'achat sur la boutique en ligne buzzbomb.buzz.
Aspire Biopharma (NASDAQ:ASBP) hat sein innovatives Pre-Workout-PrƤparat BUZZ BOMBā� erfolgreich auf der FitCon und FitExpo eingeführt und über 30.000 Testpackungen an Besucher verteilt. Das Produkt nutzt eine einzigartige sublinguale Abgabetechnologie mit 50 mg Koffein und ist in vier Geschmacksrichtungen erhƤltlich: Tropische Früchte, Gemischte Beeren, Pfirsich-Mango und Kaffee-Mokka.
Es zeichnet sich durch schnelle Aufnahme (unter 2 Minuten gegenüber den üblichen 20ā�30 Minuten), praktische Einzelportionen und prƤzises Energiemanagement aus. Bekannte Fitness-Persƶnlichkeiten, darunter der UFC-KƤmpfer Bobby Maximus und der MMA-Champion Brandon Copeland, gaben positive Testimonials. Das Produkt ist jetzt über den Onlineshop buzzbomb.buzz erhƤltlich.
- None.
- Early stage of market penetration with unproven commercial success
- Faces competition in the multi-billion-dollar pre-workout supplement market
- Dependent on successful marketing and third-party manufacturing expansion
Insights
Aspire launches innovative sublingual pre-workout supplement with promising initial market reception, representing potential new revenue stream.
Aspire Biopharma's launch of BUZZ BOMBā� represents a strategic entry into the multi-billion-dollar pre-workout supplement market with a differentiated product offering. The company has demonstrated initial market traction by distributing 30,000 sample packs at two major fitness conventions with 70,000+ combined attendees, generating immediate consumer exposure.
The product's key competitive advantages include its sublingual delivery method, which enables faster absorption (<2 minutes vs traditional 20-30 minutes), precise caffeine dosing (50mg increments), and convenient single-use packaging. This positions BUZZ BOMBā� as a potential disruptor in a crowded but growing market segment.
From a business perspective, the company has established an e-commerce sales channel (buzzbomb.buzz) and appears to be pursuing a dual strategy: direct-to-consumer sales and potential licensing partnerships with established nutritional/supplement companies. Management's mention of "high margin potential" suggests favorable unit economics, though no specific revenue projections or pricing details were provided.
The endorsements from recognized fitness personalities like Bobby Maximus and Brandon Copeland provide initial credibility, though the commercial impact of these relationships remains to be proven. The company's stated plans to partner with additional athletes and influencers indicate a marketing-driven growth strategy typical for consumer supplements.
For Aspire, this product represents the commercial application of their "multi-faceted patent-pending supplement delivery technology," suggesting BUZZ BOMBā� may be the first in a potential portfolio of similarly delivered products. Without financial projections or current revenue contribution data, it's premature to quantify the potential impact on Aspire's overall financial performance.
BUZZ BOMBā� is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout to help athletes and fitness enthusiasts maximize their performance potential
30,000 BUZZ BOMBā� sample packs of four 50mg stick packs in each flavor distributed to convention attendees
Well-known fitness instructors, fitness celebrities, athletes, and influencers along with thousands of fitness enthusiasts and consumers sampled BUZZ BOMBā�'s four bold flavors
As part of its launch, Aspire plans on partnering with well-known athletes and influencers across fitness training and endurance sports to accelerate consumer awareness and uptake
BUZZ BOMBā� is available for purchase at , the Company's new E-commerce website
ESTERO, FL / / August 13, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, today announced the successful launch and distribution of over 30,000 BUZZ BOMBā� sample four-packs, its newsublingual pre-workout supplement, at FitCon and FitExpo, held August 1-3, in Salt Lake City and Anaheim, with an estimated combined attendance in excess of 70,000 people.
BUZZ BOMBā�, featuring 50mg of caffeine and offered in four flavors (Tropical Fruit, Mixed Berry, Peach Mango, and Coffee Mocha), provides nearly instant energy, in easy-to-use small sublingual packets, which can be taken right before and during work out as needed. Unlike most pre-workout products that are mixed with water and taken well before a workout, BUZZ BOMBā� is sprinkled under the tongue right before or during a workout for immediate effect via direct delivery to the bloodstream.
BUZZ BOMBā� FitExpo Launch
BUZZ BOMBā� Testimonial from Leading Figures in the Fitness World
Bobby Maximus is a UFC fighter, Ju Jitsu Masters World Champion and fitness trainer. He has broken multiple power-endurance world records and is recognized as a leading figure in the fitness world. He starred in the recent feature film "Kill Shot" and is a best-selling Men's Health author and a regular contributor to "Men's Health" magazine ().
"In just about a minute, it feels like I drank a pre-workout 20 minutes ago."
"The tasteā� phenomenal! I really like that."
"I work out 2-3 times a day. One of the most inconvenient things is trying to time your pre workout drink 30 minutes before your workout. "
When I have a short window, I don't want to wait 30 minutes until it kicks in. The ability to just 'dump and go' with Buzz Bomb, is powerful. It's the convenience factor!
"I love the idea behind it! It helps me keep my caffeine intake down. Especially when you train 2 to 3 times a day."
"You cannot find another pre work with 50 mgs of caffeineā� and it works! I love it!"
Brandon "MidWest Kong" Copeland (pictured above, third to the right) embodies the strength of a champion and the heart of a hero. A Brazilian Jiu-jitsu Black Belt, Copeland dominated the Mixed Martial Arts scene from 2005 to 2014, showcasing tenacity and skill. Initiating the "I Stopped The Bully" campaign in 2011, he became a beacon against bullying, inspiring youth across schools and detention centers. Copeland excelled in the fitness industry, breaking records like bench pressing 225
"I took the product! Let me say thank God! No heart flutter, no itchy sensation, no crash! I don't need the hard stuff anymoreā¦feels absolutely great! I had a great workout as well!"
Commenting on the BUZZ BOMBā� launch, Kraig Higginson, Interim Chief Executive Officer of Aspire, said, "The launch and consumer response to BUZZ BOMBā� at two of the major fitness conventions, from booth activity, product sampling, feedback, interest from fitness experts and influencers, and potential licensing partners, exceeded all of our high expectations."
Higginson added, "With BUZZ BOMBā�, we're raising the bar for ease of use, performance and value in the multi-billion-dollar caffeine category. We focused on creating a formula that is fast-absorbing and built for athletes, fitness enthusiasts and consumers who demand clean, effective fuel without unnecessary fillers or compromise. With online sales commencing August 1, we are now focused on increasing our marketing, expanding our third-party manufacturing capabilities, and preparing for further discussions with potential licensing partners in the nutritional and supplement space that can help us drive increased consumer awareness and accelerate our revenue potential for BUZZ BOMBā�."
Consumers can purchase BUZZ BOMBā� online at
BUZZ BOMBā� Pre-workout Benefits:
Speed - works nearly immediately (less than 2 minutes) vs. 20-30 minutes
Convenience - easy to use single-use packets vs. mixing and measuring for beverages
Energy management - use as needed to precisely manage caffeine intake (50mg increments)
Single Safe Active Ingredient - well-known benefits and use of caffeine
A clean manageable Energy Boost
Low manufacturing & packaging costs - competitive pricing with high margin potential


Aspire's BUZZ BOMBā� - Sublingual nano technology delivers 50mg of caffeine rapidly to the body, bringing its unique benefits to the pre-workout market.
About Aspire Biopharma, Inc.
Headquartered in Estero, Fl., Aspire Biopharma has developed a patent-pending disruptive technology that can deliver supplements and drugs to the body rapidly and precisely with less negative impact to the system by going directly to the bloodstream and avoiding the gastrointestinal tract. For more information, please visit .
Safe Harbor Statement
Certain statements made in this communication are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as "estimate," "projects," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "potential," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Aspire Biopharma Holdings, Inc.
Contact
PCG Advisory
Kevin McGrath
+1-646-418-7002
[email protected]
SOURCE: Aspire Biopharma Holdings, Inc.
View the original on ACCESS Newswire